Skip to main content
Fig. 3 | Journal of Ovarian Research

Fig. 3

From: Metabolomic change due to combined treatment with myo-inositol, D-chiro-inositol and glucomannan in polycystic ovarian syndrome patients: a pilot study

Fig. 3

Metabolic systems map summarizing the shortest route that may explain the interactions among the 15 selected metabolites. There is a clear interplay of several pathways involving: Biopterin metabolism; De novo fatty acid biosynthesis; Di-unsaturated fatty acid beta-oxidation; Glycerophospholipid metabolism; Glycine, serine, alanine and threonine metabolism; Linoleate metabolism; Saturated fatty acids beta-oxidation; TCA cycle; Tyrosine metabolism; Urea cycle and metabolism of arginine, proline, glutamate, aspartate and asparagine; Valine, leucine and isoleucine degradation; Vitamin B3 (nicotinate and nicotinamide) metabolism; Vitamin E metabolism

Back to article page

Journal of Ovarian Research

ISSN: 1757-2215

Contact us